Stabilization of Renal Function Following Renal Artery Stent Revascularization

The progressive nature of atherosclerotic renal artery stenosis is now well recognized.^1–8 Observational data suggests that untreated renal artery stenosis can lead to progressive hypertension, renal insufficiency, and increased mortality.^6,9–11 The incidence of progressive ischemic nephropathy resulting from atherosclerotic renal artery stenosis had been underestimated in the past. The U.S. Renal Data System annual report in 1999 revealed that up to 20% of new patients > 50 years old requiring hemodialysis have underlying renovascular disease.¹² Medical management of hypertension associated with renal artery stenosis mainly focuses on blood pressure control. Despite reports that surgical revascularization can improve blood pressure, delay the progression of renal failure or even reverse it in some patients,^13-20 it has been reserved for patients refractory to medical management. This is mainly due to the fact that aorto-renal bypass carries with it a high morbidity and mortality (rates up to 6–8%).^16,21–25 In the last 2 decades, percutaneous revascularization with angioplasty and more recently, stenting has offered the benefit of revascularization with significantly reduced morbidity, mortality and in-hospital stay. Observational studies have reported improvement in blood pressure in a large proportion of the patients following renal artery stenting. However, the literature regarding the effect of renal artery stenting on renal function reveals conflicting results. Some authors report improved renal function in 40–100% of patients^26–38 while others found no significant impact of revascularization on renal function.^3,39–47 Others have even reported worsening of renal function following renal angiography or percutaneous revascularization in 10–40% of patients, some of them subsequently requiring hemodialysis.^{33,45,47–49} The purpose of this retrospective study is to evaluate the long-term effect of renal artery stenting (performed primarily for suspected renovascular hypertension) on renal function in patients with atherosclerotic renal artery stenosis (> 70% diameter stenosis). Methods This is a retrospective analysis of 72 consecutive patients who underwent renal artery stenting, primarily for renovascular hypertension, at a single institution. All patients had drug refractory hypertension (defined as systolic blood pressure > 140 mmHg and diastolic blood pressure > 90 mmHg despite 2 antihypertensive drugs) and > 70% diameter stenosis in one or both renal arteries. Unilateral renal artery stenting was performed in 54 patients (54/72 = 75%) and bilateral stenting in 18/72 (25%). Definitions. Acute procedural success was defined as = 1.5 mg/dl. “Improvement” in renal function was defined as decrease in serum creatinine by >= 20% compared to baseline. Renal function was considered “unchanged” if creatinine varied by = 20%. Serum creatinine levels were followed on an out-patient basis at the clinician’s discretion. Serum creatinine was evaluated at approximately 6 months, 1, 2 and 3 years post-renal artery stenting for eligible patients. Since there was no significant variation in the interim mean values, the latest serum creatinine values are presented. Paired t-test was used for validation of this comparison. A p value = 1.5 mg/dl). The renal function “improved” in 3 patients (3/17 = 18%, 2.7 ± 1 to 1.6 ± 0.6 mg/dl, p = ns), remained “unchanged” in 9 patients (9/17 = 53%), and was “worse” in 5 patients (5/17 = 29%, 2 ± 0.51 to 3.3 ± 0.34 mg/dl, p = 0.005) but none of them required hemodialysis. Seven patients (7/70 = 10%) had clinical restenosis, (3 bilateral and 4 unilateral) requiring repeat renal revascularization. Four of these patients (4/7 = 57%) had abnormal baseline creatinine and remained “unchanged” at follow-up. Three patients (3/7 = 43%) had normal baseline creatinine and remained normal at follow-up. The characteristics of the patients who experienced worsening of renal function at follow-up (with either normal or abnormal baseline creatinine) were similar to the characteristics of the total cohort (Table 3). Discussion Atherosclerotic renal artery stenosis is a progressive disease and if untreated, may lead to renal dysfunction (ischemic nephropathy) often requiring hemodialysis.^1–11 Surgical revascularization can delay the progression of renal failure, and in some cases reverse it, but is associated with high procedural morbidity and mortality.^13–25 While several retrospective studies have reported sustained hemodynamic benefits of relieving renal artery obstruction,50–52 the role of percutaneous renal artery revascularization to prevent, arrest or reverse ischemic nephropathy is much less defined. Dorros et al. have reported the largest series of patients (163 at a single institution and a multi-center registry of 1,058 patients) with up to 4-year follow-up. They found improvement or stabilization of renal function in up to two-thirds of the patients.^27,28 A number of other studies report improvement or stabilization of renal function ranging from 40–100% of patients following percutaneous renal artery revascularization.^26,29–38 On the contrary, some authors have reported significant worsening of renal function following renal stenting (in up to 10–40% of patients, with only a few requiring hemodialysis).^{33,45,47–49} This has attributed to athero-embolism or contrast nephropathy, and in the long term, to progression of diabetes or uncontrolled hypertension. In our group of patients who underwent revascularization of significant renal artery stenosis, primarily for suspected renovascular hypertension, we found that renal function remained stable in 89% of patients (54/61) and worsened in 11% (7/61) patients at 2-year follow-up. In patients with a baseline serum creatinine of 1.5 mg/dl, the renal function remained stable in 71% of them at follow-up. Despite clinical restenosis in 7 patients (7/70 = 10%), the serum creatinine remained unchanged in this group. It is possible that repeat renal revascularization contributed to maintaining stability of renal function. Two patients (2/70 = 3%) with normal baseline creatinine had worse creatinine at follow-up. This was not likely to be secondary to the use of radio-contrast or atheroembolism since the elevation in creatinine was seen late in follow-up. These 2 patients did not have clinical restenosis and had normal blood pressure at follow-up. Study limitations. 1) This is a retrospective analysis with a mean follow-up of approximately 2 years. A prospective evaluation with longer follow-up is desirable. 2) Serum creatinine was used as the marker of renal function. More accurate ways to quantify renal function, like glomerular filtration rate or nuclear renal scans were not used. 3) A serum creatinine of > 1.5 mg/dl was used to define abnormal renal function. This was not adjusted for body size. 4) Nine of the 70 eligible patients (13%) were lost to follow-up. A complete follow-up would be desirable. Conclusions In patients with atherosclerotic renal artery stenosis treated using renal artery stenting, the renal function remained stable in 89% of patients and worsened in 11% of patients at 21 months (follow-up was available in 87% of the eligible patients). In patients with baseline renal insufficiency (serum creatinine > 1.5 mg/dl), the renal function remained stable in 71% of patients.

1. Meaney TF, Dustan HP, McCormack LJ. Natural history of renal arterial disease. Radiology 1968;91:881–887. 2. Wollenweber J, Sheps SG, Davis GD. Clinical course of atherosclerotic renovascular disease. Am J Cardiol 1968;21:60–71. 3. Pohl MA, Novick AC. Natural history of atheroscl and fibrous renal artery disease: Clinical implications. Am J Kidney Dis 1985;5:A120–130. 4. Strandness DE, Jr. Natural history of renal artery stenosis. Am J Kidney Dis 1994;24:630–635. 5. Caps MT, Perissinotto C, Zierler RE, et al. Prospective study of atherosclerotic disease progression in the renal artery. Circulation 1998;98:2866–2872. 6. Cheung CM, Wright JR, Shurrab AE, et al. Epidemiology of renal dysfunction and patient outcome in atherosclerotic renal artery occlusion. J Am Soc Nephrol 2002;13:149–157. 7. Rimmer JM, Gennari FJ. Atherosclerotic renovascular disease and progressive renal failure. Ann Intern Med 1993;118:712–719. 8. Pillay WR, Kan YM, Crinnion JN, Wolfe JH. Prospective multicentre study of the natural history of atherosclerotic renal artery stenosis in patients with peripheral vascular disease. Br J Surg 2002;89:737–740. 9. Textor SC. Progressive hypertension in a patient with “incidental” renal artery stenosis. Hypertension 2002;40:595–600. 10. Novick AC, Textor SC, Bodie B, Khauli RB. Revascularization to preserve renal function in patients with atherosclerotic renovascular disease. Urol Clin North Am 1984;11:477–490. 11. Dean RH, Kieffer RW, Smith BM, et al. Renovascular hypertension: Anatomic and renal function changes during drug therapy. Arch Surg 1981;116:1408–1415. 12. Executive summary. United States Renal Data System 1999 Annual Data Report. Am J Kidney Dis 1999;34:S9–S19. 13. Novick AC, Pohl MA, Schreiber M, Gifford RW, Jr., Vidt DG. Revascularization for preservation of renal function in patients with atherosclerotic renovascular disease. J Urol 1983;129:907–912. 14. Hansen KJ, Cherr GS, Craven TE, et al. Management of ischemic nephropathy: Dialysis-free survival after surgical repair. J Vasc Surg 2000;32:472-81. Discussion:481–482. 15. Cambria RP, Brewster DC, L'Italien GJ, et al. Renal artery reconstruction for the preservation of renal function. J Vasc Surg 1996;24:371-80. Discussion 380–382. 16. Hansen KJ, Starr SM, Sands RE, et al. Contemporary surgical management of renovascular disease. J Vasc Surg 1992;16:319-30. Discussion:330–331. 17. Morris GC, Jr., De Bakey ME, Crawford ES, et al. Late results of surgical treatment for renovascular hypertension. Surg Gynecol Obstet 1966;122:1255–1261. 18. Ascer E, Gennaro M, Rogers D. Unilateral renal artery revascularization can salvage renal function and terminate dialysis in selected patients with uremia. J Vasc Surg 1993;18:1012–1018. 19. Dean RH, Tribble RW, Hansen KJ, et al. Evolution of renal insufficiency in ischemic nephropathy. Ann Surg 1991;213:446-55. Discussion:455–456. 20. Libertino JA, Bosco PJ, Ying CY, et al. Renal revascularization to preserve and restore renal function. J Urol 1992;147:1485–1487. 21. Novick AC. Current concepts in the management of renovascular hypertension and ischemic renal failure. Am J Kidney Dis 1989;13:33–37. 22. Aurell M, Jensen G. Treatment of renovascular hypertension. Nephron 1997;75:373–383. 23. Textor SC. Revascularization in atherosclerotic renal artery disease. Kidney Int 1998;53:799–811. 24. Cambria RP, Brewster DC, L'Italien GJ, et al. The durability of different reconstructive techniques for atherosclerotic renal artery disease. J Vasc Surg 1994;20:76-85. Discussion:86–87. 25. Novick AC, Ziegelbaum M, Vidt DG, et al. Trends in surgical revascularization for renal artery disease. Ten years' experience. J Am Med Assoc 1987;257:498–501. 26. Connolly JO, Higgins RM, Walters HL, et al. Presentation, clinical features and outcome in different patterns of atherosclerotic renovascular disease. Q J Med 1994;87:413-21. 27. Dorros G, Jaff M, Mathiak L, et al. Four-year follow-up of Palmaz-Schatz stent revascularization as treatment for atherosclerotic renal artery stenosis. Circulation 1998;98:642–647. 28. Dorros G, Jaff M, Mathiak L, He T. Multicenter Palmaz stent renal artery stenosis revascularization registry report: four-year follow-up of 1,058 successful patients. Cathet Cardiovasc Intervent 2002;55:182–188. 29. Rees CR, Palmaz JC, Becker GJ, et al. Palmaz stent in atherosclerotic stenoses involving the ostia of the renal arteries: Preliminary report of a multicenter study. Radiology 1991;181:507–514. 30. van de Ven PJ, Beutler JJ, Kaatee R, et al. Transluminal vascular stent for ostial atherosclerotic renal artery stenosis. Lancet 1995;346:672–674. 31. Burket MW, Cooper CJ, Kennedy DJ, et al. Renal artery angioplasty and stent placement: predictors of a favorable outcome. Am Heart J 2000;139:64–71. 32. Watson PS, Hadjipetrou P, Cox SV, et al. Effect of renal artery stenting on renal function and size in patients with atherosclerotic renovascular disease. Circulation 2000;102:1671–1677. 33. Pickering TG, Sos TA, Saddekni S, et al. Renal angioplasty in patients with azotaemia and renovascular hypertension. J Hypertens 1986;4(Suppl 6):S667–669. 34. Boyer L, Bouchet F, Boissier A, et al. Pattern of blood creatinine levels in 140 hypertensive patients after successful percutaneous transluminal angioplasty for renal artery stenosis. J Radiol 1993;74:609–613. 35. Perkovic V, Thomson KR, Mitchell PJ, et al. Treatment of renovascular disease with percutaneous stent insertion: Long-term outcomes. Australas Radiol 2001;45:438–443. 36. Rocha-Singh KJ, Ahuja RK, Sung CH, Rutherford J. Long-term renal function preservation after renal artery stenting in patients with progressive ischemic nephropathy. Catheter Cardiovasc Intervent 2002;57:135–141. 37. Taylor A, Sheppard D, Macleod MJ, et al. Renal artery stent placement in renal artery stenosis: technical and early clinical results. Clin Radiol 1997;52:451–457. 38. Harden PN, MacLeod MJ, Rodger RS, et al. Effect of renal-artery stenting on progression of renovascular renal failure. Lancet 1997;349:1133–1136. 39. Jiang X, Ming G, Wu H, et al. Preliminary results of stenting revascularization as treatment for renal artery stenosis. Zhonghua Nei Ke Za Zhi 2002;41:82–85. 40. Bonelli FS, McKusick MA, Textor SC, et al. Renal artery angioplasty: Technical results and clinical outcome in 320 patients. Mayo Clin Proc 1995;70:1041–1052. 41. Hoffman O, Carreres T, Sapoval MR, et al. Ostial renal artery stenosis angioplasty: immediate and mid-term angiographic and clinical results. J Vasc Intervent Radiol 1998;9:65–73.